A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisRoberta D’Ambrosio, Pierre Bédossa, Alessio Aghemo et al.|Hepatology|2012Cited by 404
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Pietro Lampertico, Roberta D’Ambrosio et al.|Journal of Hepatology|2020Cited by 392
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Luca Valenti, Thomas Berg et al.|Journal of Hepatology|2020Cited by 361
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationHarry L.A. Janssen, Jordan J. Feld, Harald Hofer et al.|Journal of Hepatology|2016Cited by 273
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis CMaria Grazia Rumi, Massimo Colombo, Alessio Aghemo et al.|Gastroenterology|2009Cited by 199